The differential leukocyte count
(DLC) showed gradual decrease in mean values of neutrophils, monocytes, and eosinophils in all groups.
Total and differential leukocyte count
was measured by using automated hematology cell analyser Sysmex-xt 2000i.
The data displayed that PI extract significantly ameliorated airway inflammation, goblet cell hyperplasia, total leukocyte count, and differential leukocyte count
, which might be attributed to the attenuation of TNF-[alpha], IL-4, and IL-5 expression levels.
Subsequently, milk samples were collected in the morning in sterile flasks on days 1, 2, 3, 5, 7, 9, 13 and 15 post-infusion (PI) and the SCCs and milk differential leukocyte count
(polymorphonuclear neutrophils PMNs, macrophages and lymphocytes) were evaluated.
Assessment of differential leukocyte count
in patients with acute coronary syndrome.
For example, according to the automatic determination system of chromosome karyotype of a chromosome distribution in the image, the system automatically generates differential leukocyte count
report from a blood smear.
The milk samples were collected aseptically in sterilized plastic bottles for milk total somatic cell and differential leukocyte count
(Gargouri et al., 2008).
Differential Leukocyte Count
(DLC) were not significantly affected by garlic supplementation in feed and variation in DLC may be due to the interaction of garlic with immune system.
The clinical usefulness of segmented vs slab neutrophil criteria for differential leukocyte count
. Am J Clin Pathol 1979; 6: 947-958.
Cruz et al, has also reported unaltered total and differential leukocyte count
in the peripheral blood of diabetic subjects .
Automated differential leukocyte count
in horses, cattle, and cats using the Technicon H-1E hematology system.
Differential leukocyte count
maintains diagnostic significance in two fields: (a) measurement of the relative proportions of normal leukocyte populations, with important implications, for instance, in the diagnosis and monitoring of infectious diseases and in monitoring of cytotoxic therapies; and (b) search for and definition of abnormal cells in the peripheral blood.